Study of SAF312 as an Eye Drop for Treatment of Eye Pain Following Photorefractive Keratectomy (PRK) Surgery

Completed · Phase 2 · Has a placebo group

Conditions studied: Postoperative Ocular Pain After PRK Surgery

In brief

The purpose of this study is to determine if SAF312 eye drops have an adequate safety and efficacy profile to justify further clinical development for the treatment of ocular pain associated with corneal epithelial defect such as after photorefractive keratectomy (PRK) surgery

Key facts

Study ID
NCT02961062
Run by
Novartis Pharmaceuticals
People needed
40
Starts
2016-12-01
Expected to finish
2018-02-21
Last updated by the study team
2021-10-06

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.